| Literature DB >> 31692497 |
Maryam Nadi1, Effat Bambaeichi2, Seyyed Mohammad Marandi2.
Abstract
INTRODUCTION AND AIM: The purpose of this study was to compare the effect of 12 weeks of low-intensity resistance training and exercises for peripheral neuropathy (EPN) on the inflammatory and physiological conditions, balance, and complications of diabetic neuropathy in female patients.Entities:
Keywords: CRP and diabetic neuropathy exercises; IL-10; TNF-α
Year: 2019 PMID: 31692497 PMCID: PMC6708387 DOI: 10.2147/DMSO.S206454
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Figure 1Chart of subject’s selection.
Summary of the training sessions
| EPN | Resistance | ||
|---|---|---|---|
| General exercise | Warm-up | At the beginning of each session for 10 min, no overload, with the aim of increasing the range of motion | Exactly similar to the exercises for the EPN group |
| Cool-down | At the end of each session, for 10 min, no overload, with the goal of reducing heart rate and recovery | Exactly similar to the exercises for the EPN group | |
| Specific exercises | Every move in each session is repeated for 30 seconds; after every two weeks, a 30-second repetition is added to it | Different movements of this group were followed by the same rules as done in the EPN group | |
Clinical characteristics of the studied subjects
| Control | Resistant | EPN | |
|---|---|---|---|
| N | 15 | 15 | 15 |
| Age (year) | 54.80±3.29 | 56.13±3.39 | 55.46±2.47 |
| High (cm) | 160.37±6.01 | 163.45±4.35 | 160.09±3.75 |
| Weight (Kg) | 72.67±5.43 | 72.72±7.01 | 71.53±7.01 |
| Body mass index (Kg/m2) | 27.21±2.61 | 30.41±0.12 | 28.44±14.11 |
| Diabetes duration (year) | 11.20±3.21 | 11.20±1.89 | 11.33±2.28 |
| Energy consumption (Kcal)* | 2733+0.30 | 2323±0.01 | 2625±0.12 |
| Insulin (ml/day) | 58±1.1 | 60±2.0 | 61±0.2 |
Note: *The amount of calories consumed 24 hrs a day, as considered in the pre-test and post-test.
Comparison of the inflammatory and anti-inflammatory factors and physiological and glycemic conditions of the patients before and after intervention
| Control | Resistant | EPN | F ( | ||
|---|---|---|---|---|---|
| Static balance | Pre test | 2.00±1.13 | 2.33±1.23 | 1.73±0.88 | 6.52 (0.003) |
| Post test | 2.00±1.12 | 2.73±0.79 | 3.20±0.77 | ||
| T ( | 1.61(0.13) | 2.72 (0.002) | 3.86 (0.0001) | ||
| Dynamic balance | Pre test | 1.00±0.65 | 0.67±0.48 | 0.93±0.70 | 9.55 (0.10) |
| Post test | 0.67±0.72 | 2.13±0.64 | 2.20±0.67 | ||
| T ( | 2.49 (0.02) | 0.97 (0.0001) | 1.61 (0.003) | ||
| CRP (mg/L) | Pre test | 8.53±3.1 | 8.89±5.13 | 6.67±3.34 | 2.38 (0.0001) |
| Post test | 8.54±3.21 | 7.57±2.84 | 5.72±2.84 | ||
| T ( | −0.139 (0.891) | 4.37 (0.001) | 4.16 (0.001) | ||
| FBG (mg/dl) | Pre test | 114.53±5.89 | 118.00±7.24 | 115.40±7.03 | 10.94 (0.0001) |
| Post test | 115.86±5.01 | 103.13±9.40 | 108.26±7.43 | ||
| T ( | −2.28 (0.03) | 8.81 (0.0001) | 5.91 (0.0001) | ||
| Systolic blood pressure (mmHg) | Pre test | 139±16.10 | 142±16.01 | 140±12.10 | 12.21 (0.0001) |
| Post test | 140±16.00 | 139±16.31 | 136±21.1 | ||
| T ( | −11.1 (0.21) | 7.31 (0.001) | 6.28 (0.0002) | ||
| Heart rate (beats/min) | Pre test | 74±11.10 | 73±10.10 | 74±11.10 | 5.21 (0.0001) |
| Post test | 74±11.12 | 72±0.90 | 73±10.12 | ||
| T ( | −3.20 (0.1) | 4.11 (0.002) | 6.21 (0.0001) | ||
| HbA1c (%) | Pre test | 8.37±0.67 | 8.49±0.80 | 7.63±1.16 | 8.82 (0.001) |
| Post test | 8.37±0.67 | 7.11±1.13 | 7.52±0.60 | ||
| T ( | −1.0 (0.33) | 7.70 (0.0001) | 6.64 (0.0001) | ||
| Postprandial plasma glucosa (mg/dl) | Pre test | 255.46±30.54 | 277.33±41.53 | 262.73±43.53 | 4.91(0.001) |
| Post test | 262.06±31.21 | 224.06±36.50 | 225.86±43.60 | ||
| T ( | −3.44 (0.4) | 6.29 (0.0001) | 4.99 (0.0001) | ||
Figure 2Concentration of cytokine in the pre-test and post-test in the three groups. (p<0.05).
Abbreviations: TNF-α, tumor necros is factor-α; IL-10, interleukin 10.
Symptoms of diabetic neuropathy
| Control | EPN | Resistance | X2 | Sig | |||
|---|---|---|---|---|---|---|---|
| Pain | Per test | Are | 11 | 13 | 9 | 2 | 0.25 |
| Are not | 4 | 2 | 6 | ||||
| Post test | Are | 11 | 5 | 0 | 17.65 | 0.0001 | |
| Are not | 4 | 10 | 15 | ||||
| Numb | Per test | Are | 10 | 13 | 9 | 2.81 | 0.24 |
| Are not | 5 | 2 | 6 | ||||
| Post test | Are | 10 | 5 | 2 | 9.26 | 0.10 | |
| Are not | 5 | 10 | 13 | ||||
| Tingling | Per test | Are | 12 | 10 | 10 | 0.86 | 0.64 |
| Are not | 3 | 5 | 5 | ||||
| Post test | Are | 11 | 7 | 3 | 8.57 | 0.001 | |
| Are not | 4 | 8 | 12 | ||||